mcal® expands its range with calcium citrate powder

BROSSARD, April 24, 2026 – mcal® announces the launch of mcal® Calcium Citrate Powder for Oral Suspension, a new option designed to facilitate daily calcium administration, particularly in settings where ease of use and dosing accuracy are essential.

BROSSARD, April 2, 2026 — Mantra Pharma is proud to announce the acquisition of the Quebec-based company Cutimed, manufacturer of the Cutibase dermatological skincare line, well known among dermatologists and pharmacists and widely distributed in pharmacies across Quebec.

Effective December 15, 2025, Mantra Pharma Inc. will no longer be responsible for promoting Ulticare® products on behalf of Stericycle Inc.

BROSSARD, March 17, 2025 – Myriad Pharma, the division of Mantra Pharma specializing in the marketing of over-the-counter products, is expanding its representation network with two new partners: Laboratoire Modilac and La ligne J'ARRÊTE.

BROSSARD, January 20, 2025 – Mantra Pharma, a leading Quebec-based developer and marketer of generic medications, announces the upcoming launch of M-METFORMIN, an addition to its generic range.

We are delighted to share that Mantra Pharma proudly took part in the 2024 Noeudvembre campaign, organized by PROCURE. Held throughout November, this annual effort is dedicated to raising public awareness and funding critical research in the fight against prostate cancer, the most common cancer among men.

Canada, as many other countries, has taken serious steps to address and eradicate from its supply chains exploitative practices such as forced labour and child labour. Mantra Pharma Inc. (“Mantra Pharma”) is committed to respect the human rights and adopt a zero-tolerance approach to forced labour and child labour and act ethically in all its business relationships.

BROSSARD, QC, February 8, 2024 – At the height of the season when respiratory viruses are on the rise in the population, Mantra is solidifying its supply of an oral antibiotic whose shortage last year caused major issues for medical staff and parents of sick children.

Brossard, January 5, 2024—People suffering from dyslipidemia, a frequently trivialized and even neglected silent disease, often underestimate its impact. Although drug therapy alternatives are available on the market, Mantra Pharma is pleased to inform people with dyslipidemia that a new natural solution is now available to help them optimize their lipid profile and improve their cardiovascular health. The product, named Cardiosmile, is now available behind the counter in Quebec pharmacies.